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Abstract
A reported 33% of eukaryotic proteins are predicted to contain intrinsically disordered regions
(IDRs) over 30 residues in length. IDRs are regions of protein which natively exist in an unfolded
conformation. Due to their highly dynamic nature, many common methods of inquiry such as
crystallography and NMR can be thwarted. As a result, valuable analysis such as probing function,
dynamics and binding interfaces are unable to be performed. To minimize these problems,
researchers typically study shorter IDRs. We probed fragments of plant protein villin 4 (VLN4) for
covalent modifications to explore its regulation and degradation. Disordered regions of proteins
have greater solvent accessibility compared to their folded counterparts. This results in various
post translational modifications, a common method of protein regulation. The protein VLN4 is
vital to the development of roots and understanding its regulation could greatly benefit
agriculture. Thus, VLN4 was examined for degradation, ubiquitination, and phosphorylation.

Complimentarily, overcoming challenges of IDR research can be done by targeting the IDR with
covalent modification via sortase-mediated ligation (SML). In NMR, large IDRs create substantial
spectral overlap in the 1H dimension for backbone amide protons. By introducing isotopically
labeled residues with SML, this overlap can be greatly reduced and allow for characterization of
longer IDRs. Through the use of authentic IDRs with extreme pentapeptide residue properties on
N- and C- terminal flanking regions of LPXTG motifs, ligation efficiencies were characterized,
followed by identification and optimization of problematic sortase ligation sequences.
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Chapter I – Introduction
Plant Villin 4 and Its Homologs
Proteins with Intrinsically Disordered Regions. Intrinsically disordered regions (IDRs) are natively
unfolded regions of proteins.1 Of eukaryotic proteins, 33% contain IDRs over 30 residues long.1
Classically, proteins were viewed in a structure-function manner, however modern literature
reveals IDRs and intrinsically disordered proteins (IDPs) to be multifunctional and perform vital
cellular processes.1–4 Possessing a greater understanding of these proteins would greatly benefit
the greater scientific community across disciplines.

Plant Villin 4 and IDR Length is Related to Function. The protein villin 4 (VLN4) is involved in the
development of plant root hairs through F-actin bundling.5,6 This functionality is essential to the
vitality of crops and requires further study for the next generation of agriculture. 6 To better
understand VLN4 and its function, IDR length can be a good indicator.1,4 IDRs’ lengths follow a
power law distribution: more proteins contain shorter IDRs than longer IDRs.1 The length of an
IDR is also directly related to the probability of their function and in vivo post-translational
modifications.1,4 IDRs with less than 10 residues typically function as linkers; IDRs with more than
30 residues can contain domains functioning in recognition; while IDRs of 300-500 residues are
typically enriched to promote kinase and phosphatase functionality.1 The IDR of VLN4 is 190
residues long, which presents not only possibilities of function recognition, but also borders into
kinase/phosphatase functionality. This in and of itself is not enough evidence to warrant a VLN4
covalent modification study. However, plant villins have homologs which possess these same
previously studied modifications.

Plant Villin Homologs. The homo sapiens cytoskeletal regulator dematin is a homolog of VLN4.
Both dematin and its Arabidopsis thaliana counterpart have significant structural similarities
(large IDRs connected to C-terminal headpiece domains, and 3D structure within the headpiece
domains), both bind and bundle actin filaments, and phosphorylation was either shown or
predicted in both. (Figure 1.1).7–9 These structural and functional similarities suggest plant villin

1

may also undergo covalent modification. However, literature has yet to report post-translational
covalent modifications within VLN4’s IDR.

a

b

Figure 1.1. (a) 2D structural and actin binding comparison between the complete native
sequences of supervillain, dematin, and plant villin. The actin binding site on the IDR of plant villin
is shown transparent as it has been described in the Smirnov lab (2022, Jake Heins, data not
shown) (b) 3D structural alignment in PyMOL between 68 C-terminal residues of human dematin
headpiece (PDB ID: 1QZP) (green) and 63 C-terminal residues of VLN4 (PDB ID: 5VNT) (red) with
a rmsd of 1.200.

Figure 1.2. Sequence alignment comparing similarity between the folded headpiece domains of
human dematin and VLN4. VLN4 63 C-term residues (top sequence). Human dematin 68 C-term
residues (bottom sequence).

2

A comparison of dematin (68 C-term residues) and VLN4 (63 C-term residues) sequences reveals
53% of the native residues to be similar or identical (Figure 1.2). Most of these residues are within
the folded headpieces of the proteins. Folded domains are highly conserved regions. In this case,
dematin and VLN4’s headpieces both perform the same function of bundling actin filaments, and
this sequence homology is expected. Where the proteins differentiate however, is within their
IDRs. The order of sequences in disordered regions are less conserved than in their structured
counterparts.10 This is due to disordered regions’ higher mutation rates, as mutations are less
detrimental to function than in structured regions.10 As such, further inquiry is required to
determine what kinds of covalent modifications may be present in VLN4’s IDR.

Plant Villin 4 Modification and Regulation
Covalent Modification and Protein Regulation. Covalent modification is a frequent method of
protein regulation used in biological systems.11–13 Examples of this can be seen with the addition
of ubiquitin to mark proteins for degradation, 14 or the reversible monophosphorylation of serine
residues to turn on/off activity.13,15

Figure 1.3. Visual representation of ubiquitination of proteins. Ubiquitin is activated by an
enzyme known as E1, followed by ubiquitin’s transferal to another enzyme known as E2. Finally,
a third enzyme (E3) binds the target substrate and coordinates the covalent attachment of
ubiquitin.15,16
3

Degradation and Ubiquitination. Degradation of IDRs can be caused enzymatically via proteolysis
by the proteasome.15 Ubiquitin’s involvement in this process (the ubiquitin-mediated pathway)
is a major regulatory mechanism.16 Ubiquitin can serve non-proteolytic roles; however, the
protein’s major function appears to be targeting proteins for degradation. 15,16 To do so, the
carboxyl terminus of ubiquitin is activated by ATP and transferred to lysine amino acid groups by
one of several ubiquitin ligases.15,16 Additional ubiquitin is attached, creating ubiquitin-chains,
which recruit a protease for degradation (Figure 1.3).15,16

Within the native residues of atVHP164 there are 21 lysine residues, 14 of which were predicted
by the program Prediction of Ubiquitination sites with Bayesian Discriminant Method (BDM-PUB)
to be within a threshold of 0.3, indicating a strong likelihood of being ubiquitinated (Figure 1.4).

Figure 1.4. VLN4 protein fragment construct atVHP164 sequence and the amino acid residues
predicted by NetPhos-3.1 and BDM-PUB to undergo phosphorylation and ubiquitination
respectively.

Phosphorylation. Specifically, in IDPs, covalent modification of IDRs has already been shown to
produce conformational changes.17 These changes in protein conformations can also be good
indicators of an alteration in functionality.17–19 In addition to ubiquitination, another common
covalent modification is phosphorylation. The addition of phosphate groups to amino acids can
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produce a conformational change and act like a switch to turn on and off functionality of the
protein. The native sequence of atVHP164 was analyzed with NetPhos-3.1 software to predict
potential sites of phosphorylation. In erythrocytes, dematin was revealed to be phosphorylated
by cAMP-dependent protein kinase.8 With use of NetPhos-3.1, a generic phosphorylation site
predictor in eukaryotic proteins, analysis revealed one cAMP-dependent kinase (also known as
PKA) site at residue 164 of atVHP164 with a score of 0.588 indicating a high probability of
phosphorylation. Furthermore, additional kinase (CKI, CKII, cdc2, cdk5, DNAPK, GSK3, p38MAPK,
PKC, PKG, and RSK) sites received scores greater than 0.5 (Figure 1.4).

When the predicted phosphorylation sites of atVHP164 are cross-referenced with the predicted
sites of human dematin using NetPhos-3.1 software, the evolutionarily conserved residues
further point to the expectant covalent modification homology between these proteins. In vitro
confirmation of these modifications in VLN4 would provide a better understanding of its
regulation and could open avenues of improved agriculture with increased viability and yield
even in harsh environments.

Genetic Engineering and Drought Resistant Crops. As the climate changes, water shortages have
become exacerbated.20 One of the largest users of fresh water in the world is agriculture.21 Root
hairs enable plants to grow in dryer soils, with limited impact on crop yields.22 Healthy root
systems have also been shown to increase the water retention of soil.23,24 The threat of climate
change and the promise of plant root hair modification reveal the need to identify effectors of
root hair growth and maintenance. Villin 4 is integral to the proper development of root hair
filaments.9 This was shown by knock-out of the VLN4 gene.9 When the VLN4 gene was knockedout, root hairs were shown to be much shorter, suggesting that study of possible up-regulatory
mechanisms of VLN4 activity may positively impact the development of root hairs and their tip
growing cells in coordination with environmental cues. However, before genetic engineering can
take place, VLN4’s covalent methods of regulation must be explored.

5

IDR Reporter Labels with Sortase Mediated Ligation
IDR Structure and Functional Analysis. Following the long-explored structure-function mindset,
the scientific community continues to peruse innovative ways to discern the evasive
conformations of disordered proteins. A common method like nuclear magnetic resonance
spectroscopy (NMR) can be used to study disordered protein’s structure and dynamics.
Unfortunately, proteins with long IDRs can be too dynamic to analyze with prevalent NMR
techniques, causing severe spectral overlap in the 1H dimension. A method to reduce spectral
overlap can be to record for longer durations; however, proteins with large IDRs also typically
have shorter lifespans. In the case of human dematin, previously 68 residues of the C- terminal
domain were reported, leaving 315 residues of the IDR to be characterized (Figure 1.5 (a)).25

a

b

Figure 1.5. (a) Human Dematin headpiece (68 residues) displaying the dynamic nature of the IDR
in contrast to the folded domain (PDB: 1QZP). (b) Solution

15N-HSQC

NMR spectra of PEST-

replaced human dematin headpiece.26

For functional analysis, 15N and 13C-HSQC (heteronuclear single quantum coherence) NMR can be
used to probe secondary and tertiary structures of proteins. Previously, dematin was probed for
phosphorylation of the headpiece using this method but phosphorylation was unable to be
determined as the presence of phosphorylation was obscured by IDR resonances.12 Traditional
go-to methods have failed at solving these complex structures and are in urgent need of new
techniques.

Segmental Labeling and Site-Specific Labeling. In large IDRs (>100 residues) segmental labeling
with isotopic labels (15N, 15N/13C) presents a uniquely powerful solution that can resolve NMR
6

spectral overlap.27 Instead of analyzing an entire protein of interest, smaller portions can be
visualized, substantially decreasing the problematic overlap. With this technique, regions of
interest such as the circled residues clustered in figure 1.5 (b) could finally be resolved. But for a
new NMR technique to take hold, not only does it have to be effective, it must also be versatile.

Sortase Mediated Ligation and Amino Acid Properties. Sortase enzyme can be used to link two
otherwise separate polypeptide fragments together (Figure 1.6).28 Sortase does this by
recognizing LPXTG motifs (where “X” refers to any amino acid). It cuts between the threonine
and glycine residues, then joins the carboxyl group of threonine to the foreign polypeptide Nterminus.28 Due to the high specificity of the LPXTG binding interface, challenges can arise when
segmentally labeling via sortase mediated ligation (SML). Amino acid properties in flanking
residues around the LPXTG site could impact the ability of sortase to create a binding interface
and diminish ligation efficiency. Previous literature reported single residue effects on ligation
efficiency.29 Amino acids A, D, E, G, I, P, S, T, and V were shown to initially slow the formation of
the ligation product when amino acid X in DnpALPXTG was replaced, when compared to
methionine in the X position.29 In order to assess the utility of SML for in IDRs, further
investigation of other sequence effects, such as LPXTG flanking region’s chemical properties is
needed.

Figure 1.6. A depiction of a sortase mediated ligation reaction between N- and C-terminal
domains.

Abundance of Sortase Mediated Ligation Sites in IDRs. With the objective of designing an
adaptive method for future researchers to solve IDR structures, our lab created a novel software
7

named Sortase Ligation for Intrinsically Disordered Regions (SLIDRs) to determine how many
LPXTG sites were available within native, large IDRs. The SLIDRs algorithm and software was
recently developed by Dr. John Antos and Dr. Serge Smirnov (WWU/Chemistry) (unpublished
data). Disordered proteins have eluded the scientific community for a while. So much so, a
database called The Database of Protein Disorder (DisProt) and several others were created.
DisProt contains over 600 experimentally verified proteins.30–32 Of these, our lab identified 625
IDRs greater than 100 residues in length. Using these, SLIDRs revealed over 8000 LPXTG sites
available within 2 point mutations, indicating one LPXTG site about every 50 residues, supporting
the potential widespread, versatility this method presents (table 1.1).

Table 1.1. SML sites identified within DisProt IDRs using in-house novel SLIDRs software designed
by Dr. Sergey Smirnov and Dr. John Antos (WWU/Chemistry) (unpublished data).

8

Chapter II – Materials and Methods
All recipes in Materials and Methods section can be found in Appendix I

Plant Villin 4 Sequences
Fragment atVHP63srt. The VLN4 fragment named A. thaliana (at), villin headpiece (VHP), all 63
ordered residues from the C-terminus (63), contained a glycine spacer residue spacer allowing
for sortase (srt) mediated ligation after TEV protease cleavage. This construct (Figure 2.1 (a))
from the N-terminus to C-terminus contained a 6xHis affinity tag followed by a TEV cleavage
motif, one glycine spacer residue, and then the complete folded headpiece domain of VLN4.

Fragment atVHP164. The fragment of VLN4 which was examined for post-translational
modification is named atVHP164: at (A. thaliana), VHP (villin headpiece), 164 amino acid residues
from the C- terminus (Figure 1.3). From N- to C-terminal: a 72-residue long FH8 purification tag
is followed by a TEV cleavage site. This allows for native experiments with the VLN4 fragment.
Residues 135-140 were replaced with a (His)6 purification tag, as the native residues form a PEST
motif. PEST sequences are rich in proline, glutamic acid, serine, and threonine and are
hypothesized to promote rapid degradation.33 Not only does the mutation of this motif ensure
greater stability in atVHP164, but also an additional way to purify the protein (Figure 2.1 (b)).

Fragment sVL191h. Plant villin 4 fragment construct named strep tag (s), villin linker (VL), 191
residues of the disordered linker with an 8xHis tag (h) contained the entire villin 4 disordered
linker (Figure 2.1 (c)). This construct from the N-terminus to C-terminus contained a methionine
(this was unintentionally included in the expressed protein, but should not affect the validity of
results), an affinity strep tag, spacer residues to increase flexibility, strep tag, three glycine spacer
residues to increase flexibility and aid in the adherence of the strep tags to the strep-tactin
affinity chromatography resin, two glycine spacers, and a 8xHis tag for immobilized metal affinity
chromatography (IMAC). Two purification tags were included to add additional purification
techniques able to be performed and also to protect both ends of the disordered protein from
degradation.
9

a

b

c

Figure 2.1. Schematic of VLN4 protein fragment constructs used. At the top right of each panel is
a cartoon depiction where the fragment is located in relation to the full VLN4 protein. (a)
atVHP63srt, (b) atVHP164, and (c) sVL191h used in the A. thaliana plant extract trials. Methionine
is included on the N-term of sVL191h’s sequence to denote its presence in the protein expression.

Sortase Mediated Ligation Sequences
Construct Design. Sortase mediated ligation constructs were designed to test the effects of
LPXTG flanking residue properties on ligation efficiency. All constructs were designed from N- to
C-terminus as follows: FH8 affinity tag, TEV cleavage site, spacer residues, experimental extreme
residue pentapeptide flanking region, LPXTG, glycine spacer, and 6xHis affinity tag (table 2.1).
Ligation partners were designed as follows: glycine residue, C-terminus extreme flanking region
residues, and a modified lysine residue to include a fluorophore (K(DNP)) for UV-Vis at 356 nm.

10

Table 2.1. Sequence alignment of sortase mediated ligation constructs. Bold: FH8 affinity tag;
green: TEV cleavage site (ENLYFQG); underlined: linker residues; highlighted yellow:
experimental flanking region; orange: histidine affinity tag.

Protein Production
Plasmid Design. The genes encoding atVLN4 variants and SML constructs were acquired from
GenScript and were cloned into pET-24a(+) plasmid backbones.
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Plasmid Transformation. (Time Allocation: 2.5 hours) GenScript plasmids (~4 µg per vial) were
prepared by centrifuging at 6000 x g for one minute followed by the addition of 20 µL of nanopure
water. The plasmids were then vortexed for one minute and centrifuged again at 6000 x g for 30
seconds. An aliquot of GoldBio chemically competent BL21(DE3) E. coli cells was chilled on ice for
30 minutes followed by the addition of 1 µL of plasmid. The BL21(DE3 E. coli cells and plasmid
were gently flicked 4-5 times to mix, then transformed by heat shock at 42°C for 15 seconds.
Immediately following this the cells were chilled in an ice bath for 2 minutes. 500 µL of GoldBio’s
proprietary Competent Cell Recovery Medium was added and the cells were incubated for 45
minutes at 37°C, 210 rpm. The cells were plated on kanamycin (50 µg/mL) LB agar plates (15 g/L
agar, 5 g/L yeast extract, 10 g/L Bacto tryptone, 10 g/L NaCl) and incubated upside down
overnight.

Protein Expression. (Time Allocation for Day 1: 10 mins.) An isolated transformant was dabbed
with a sterile pipette tip. The tip was ejected into 100 mL of LB (10 µg/mL kanamycin, 5 g/L yeast
extract, 10 g/L Bacto tryptone, 10 g/L NaCl) and incubated overnight at 37°C, 210 rpm (12-16
hours).

(Time Allocation for Day 2: 7-10 hours) From the overnight growth, 25 mL was added to 1L of LB
and grown at 37°C, 210 rpm until an optical density between 0.5 and 0.6 at 600 nm was reached
(2-4 hours). (Remaining overnight growth was mixed with glycerol to create a concentration of
20% glycerol. This cell-glycerol mixture was flash frozen in liquid nitrogen and stored at -80°C as
a cell stock for future use). The growth was spiked with 1 mL of 0.8 M IPTG and continued to
shake at 37°C, 210 rpm for 4-5 hours. The growth was centrifuged for 30 minutes at 12,785 x g,
4°C. The supernatant was poured off and the cell pellet was scraped into a falcon tube and flash
frozen with liquid nitrogen, then stored at -20°C.

Soluble Protein Extraction. (Time Allocation: 2.5 hours) The cell pellet was resuspended in 10 mL
of relevant lysis buffer. For the VLN4 project IMAC purification: (300 mM NaCl, 10 mM imidazole,
50 mM NaH2PO4, pH 8.0); SML project IMAC purification: (50 mM Tris, 150 mM NaCl, pH 7.6);
12

and all HIC purifications: (50 mM Tris, 150 mM NaCl, 5 mM CaCl2, pH 7.6). The pellet was vortexed
until homogenized, then 10 µL of lysozyme (50 mg/mL) was added. The falcon tube cap was
wrapped in Parafilm and incubated horizontally on the shaker at ~70 rpm on ice for 30 minutes.
The cells were sonicated with a 15 mm tip using two, 35 second pulses, with a duty cycle of 60
and micro limit of 6. Sonication was followed by the addition 10 µL of DNase (10 units/µL). The
falcon tube cap was wrapped with parafilm and incubated horizontally on the shaker at ~70 rpm
at room temperature for 30 minutes. Immediately after the lysate was transferred to a centrifuge
bottle and centrifuged at 40,000 x g for 30 minutes, 4°C. The resultant supernatant was then
decanted onto a falcon tube for affinity chromatography.

Immobilized Metal Affinity Chromatography (IMAC) Purification for His Tagged Proteins
Ni-NTA Purification. (Time Allocation: 4 hours) 3 mL of Ni-NTA resin was pipetted into a 1.5 X
12.5 cm, 20 mL DWK Life Sciences Kimble borosilicate chromatography column. The resin was
washed with 2 bed volumes (BVs) of nanopure water, followed by 2 BVs of IMAC lysis buffer.
After draining, the column’s tip was capped, and cell lysate was added to the column. The top of
the column was capped and sealed with parafilm. The column was incubated on the shaker at
~70 rpm on ice for 30 minutes. After incubation, the column was gently perturbed to resuspend
the resin. The column was clamped upright on a ring stand. Once the resin had settled flow
through was collected in an autoclaved falcon tube. The resin was then washed with 1 mL
additions of IMAC wash buffer for a total of 3 BVs (the resin is fully eluted each time). After
washing, the column tip was capped, and the resin was suspended in 0.5 BVs of IMAC elution
buffer. After 30 minutes the eluant was collected. 5 BVs of IMAC elution buffer was added to the
column in 1 mL fractions. Each fraction was fully eluted before the addition of the next (the next
aliquot was added before the

Ni-NTA Resin Cleaning. (Time Allocation: 1 hour) After every use the Ni-NTA resin was washed
with 2 BVs of IMAC elution buffer followed by 2 BVs nanopure water, 2 BVs MES buffer, 2 BVs
nanopure water, 2 BVs of 20% ethanol and then stored in 20% ethanol at 4°C.

13

Ni-NTA Resin Regeneration. (Time Allocation: 3 hours) After every five uses the Ni-NTA resin was
washed with 10 BVs of nanopure water followed by 10 BVs of 100 mM EDTA, 10 BVs of nanopure
water, 10 BVs of IMAC wash buffer, 10 BVs of nanopure water, 10 BVs of 100 mM NiSO4, 10 BVs
nanopure water, 10 BVs of 20% ethanol and then stored in 20% ethanol at 4°C.

Hydrophobic Interaction Chromatography (HIC) Purification for FH8 Tagged Proteins
HIC Protein Purification. (Time Allocation: 4 hours) 8 mL of HIC resin was pipetted into a 1.5 X
12.5 cm, 20 mL DWK Life Sciences Kimble borosilicate chromatography column. The resin was
washed with 2 bed volumes (BVs) of nanopure water, followed by 2 BVs of FH8 binding buffer.
After draining, the column’s tip was capped, and cell lysate was added to the column. The top of
the column was capped and sealed with parafilm. The column was incubated on the shaker at
~70 rpm on ice for 20 minutes. After incubation, the column was gently perturbed to resuspend
the resin. The column was clamped upright on a ring stand. Once the resin had settled flow
through was collected in an autoclaved falcon tube. The resin was then washed with 1 mL
additions of FH8 wash buffer for a total of 6 BVs. After washing, the column tip was capped, and
the resin was suspended in 1 mL of FH8 elution buffer. After 10 minutes the eluant was collected.
An additional 14 mL of FH8 elution buffer was added to the column in 1 mL fractions. Each
fraction was fully eluted before the addition of the next.

HIC Resin Cleaning. (Time Allocation: 3 hours) After every use the HIC resin was washed with 2
BVs of FH8 elution buffer followed by 2 BVs of nanopure water, 4 BVs of 0.75 M NaOH, 3 BVs of
nanopure water, 4-10 BVs of 30% isopropanol, 3 BVs of nanopure water, 2 BVs of 20% ethanol
and then stored in 20% ethanol at 4°C. In our experience, after about 30 times of use, we saw a
noticeable loss of HIC resin binding capacity.

HIC Resin Regeneration. HIC does not require a separate regeneration protocol. HIC resin is
regenerated during cleaning.
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Gel Electrophoresis
Casting Electrophoresis Gels. (Time Allocation: 1.5 hours) This protocol makes 2, 10-lane gels.
Two Bio-Rad Mini-PROTEAN integrated 1.0 mm spacer plates were thoroughly cleaned and dried
with a Kimwipe and clamped into a Mini-PROTEAN casting tray with their respective clean and
dry Mini-PROTEAN short plates. These were then pressed firmly into the foam of a Mini-PROTEAN
casting stand to form a water-tight seal. In a 20 mL beaker, 6.00 mL of resolving solution was
thoroughly mixed with 3.76 mL of 40% acrylamide. Following this, 100 µL of 10% APS and 15 µL
of TEMED were rapidly mixed in (added within 3 seconds of each other). After thorough mixing
for 5 seconds the liquid was pipetted into the empty glass plates. The liquid should come up to 1
cm from the bottom of the combs when inserted. The remaining volume in the glass plates was
filled with 30% isopropanol. (The gels are completely filled with isopropanol, as opposed to a thin
layer, to break any surface tension and force the resolving acrylamide layer to lay flat).

After 30 minutes the isopropanol was drained, and the inside of the plates were carefully dabbed
with a Kimwipe to remove any remaining of the isopropanol. (If isopropanol remains, it will cause
the resolving and stacking portion of the gels to separate. If a large amount isopropanol remains
it will cause the protein lanes to merge). In a 20 mL beaker, 2.64 mL of stacking solution was
thoroughly mixed with 0.62 mL of 40% acrylamide. Following this, 33.2 µL of 10% APS and 15 µL
of TEMED were rapidly mixed in (added within 3 seconds of each other). After thorough mixing
for 5 seconds the liquid was pipetted, filling the remaining empty space in the glass plates. A
Mini-PROTEAN 10 well comb was inserted into each plate. Excess acrylamide solution spilt out.
This liquid was lightly dabbed with a Kimwipe to ensure the curing gels were not jostled.

Performing Gel Electrophoresis. (Time Allocation: 3.5 hours) Glass gel plates were placed on each
side of the Mini-PROTEAN Tetra Electrode Assembly, so their exposed combs faced inward. If
performing electrophoresis with one gel, a gel was replaced with an empty glass spacer and short
plate and positioned with the exposed comb section facing away, creating a buffer dam. The
electrode assembly was filled with new SDS running buffer and checked for leaks. If leak free, the
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buffer tank was filled to the 4-gel mark with used SDS running buffer. The gel combs were
removed, and the electrode assembly was topped off with SDS running buffer.

15 µL of sample was mixed in an Eppendorf with 5 µL of 4X SDS stain. From this, 15 µL of the
Eppendorf contents was loaded (1.0 mm 10 well plates hold a maximum of 44 µL). (Loading 5 µL
less than the total sample volume ensures no air will be pipetted, increasing the consistency
between samples). For a molecular weight standard, 5 µL of Thermo Fisher Scientific Spectra
Multicolor Broad Range Protein Ladder was loaded into a lane. Electrophoresis was conducted at
90 volts until the protein front reached the green silicone gasket of the Mini-PROTEAN Tetra
Electrode Assembly.

Gel Electrophoresis with Chromatography Resin. (Time Allocation: 3.5 hours) Resin was
resuspended in 1 mL of chosen buffer per 8 mL of resin (with or without protein bound). 5 µL of
suspended resin was pipetted into an Eppendorf along with 5 µL of 4X. The samples were loaded,
and the gel was set to 60 volts until the gel front reached the green silicone gasket of the
electrode assembly. (This method was tested with IMAC and HIC resin).

Insoluble Protein Sample Gel Preparation. (Time Allocation: 1 hour) 1 mL of LB growth culture
was pipetted into an Eppendorf. The Eppendorf was spun down for 5 minutes at 6000 rpm (9500
RCF) at room temperature. The supernatant was decanted, and the cell pellet was washed with
ddH2O and decanted. The pellet was then suspended in 10 µL of cell cracking buffer via vortexing.
The cells were scraped against the inside of the Eppendorf wall with a metal spatula ~30 times to
break down the cells further. The Eppendorf was boiled in water for 10 minutes. Scaping and
boiling were repeated for a total of three times.

Arabidopsis Thaliana Extract Protocols
Plant Cell Extract. (Time Allocation: 1 hour) (This is a modified method adopted from Dr. Jeff
Young’s lab). A mortar and pestle were chilled in a freezer (-20°C) for at least two hours. To this,
1.0 grams of frozen plant matter was placed into the chilled mortar and ground with the addition
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of 1.0 mL room temperature PIPES buffer. Once the plant matter became a homogeneous liquid,
it was centrifuged at 40000 RCF for 30 minutes, 4°C. The supernatant was decanted and 0.22 µm
filtered. (The filtered supernatant was the product of this protocol).

Plant Extract and Villin 4 Incubations. (Time Allocation: 3 hours) 50 µL of A. thaliana plant cell
extract was incubated in 10 µL of VLN4 construct (7-9 μg of protein). Depending on the construct
used, it can appear on the gel drastically different. Villin 4 headpiece containing domains typically
create thicker bands.

Control lanes were diluted with an equal volume of the missing component’s buffer. For example:
the sample of lane 2 in figure 2.2 consisted of 10 µL of sVL191h and 50 µL of PIPES buffer (A.
thaliana plant extract was in PIPES buffer). In lane 3, the sample consisted of 10 µL of strep
elution buffer and 50 µL of A. thaliana plant extract (sVL191h was strep elution buffer).

Figure 2.2. 15% SDS-PAGE of determined optimum protein loading concentrations for VLN4
fragment covalent modification trials in A. thaliana extract. Lane 1: molecular weight standard;
lane 2: protein sVL191h; lane 3: A. thaliana plant extract; lane 4: sVL191h and plant extract.

Plant Extract and Villin 4 Purification with Affinity Chromatography. (Time Allocation: 3 hours)
Strep-tactin resin was used for affinity chromatography of sVL191h. A strep purification was
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performed as it has higher selectivity than Ni-NTA resin. Samples of experimental protein
construct and plant extract were collected prior to incubation and flash frozen. These were used
for controls in SDS-PAGE. About 2000 µg of protein was mixed with 1000 µL of A. thaliana extract.
A sample was taken from this mixture and flash frozen for SDS-PAGE later. Strep purification was
immediately performed. As fractions eluted, samples were taken for SDS-PAGE and flash frozen
to prevent degradation. As an example, figure 2.3 shows the resulting gel from this purification
technique.

Figure 2.3. 15% SDS-PAGE of a Strep-Tactin resin purification of the exposure of sVL191h in A.
thaliana plant extract.

Protein Buffer Exchange and Storage
Desalting Column. (Time Allocation: 2 hours) The cap of the desalting column was removed, and
the buffer solution was poured off into the appropriate waste container. (The column cannot run
dry). 20 mL of desired buffer was added to the column. The column tip was removed, and the
buffer was eluted. Once the buffer had completely eluted 3 mL of sample was added to the
column. If sample was less than 3 mL, desired buffer was added to make a total volume of 3 mL.
The column was drained. 8 mL of desired buffer was added to the column and 1 mL fractions
were collected. (Higher molecular weights will elute first)
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Spin Concentrator. (Time Allocation: 1.5 hours) Spin concentrators were utilized for buffer
exchange when volumes were greater than 3 mL. The protein sample was spun at 5000 rpm (8000
RCF) in a Millipore Amicon Ultra-15 Centrifugal Filter Unit (30 kDa MWCO) for proteins above 30
kDa and Pall Macrosep Advance Centrifugal Devices with Omega Membrane (3 kDa MWCO) was
used for proteins below 30 kDa. Once ~3 mL of sample remained, about 20 mL of desired buffer
was added and the filter was centrifuged at 5000 rpm (8000 RCF) for 30 minutes. The remaining
liquid (~ 5 mL) was pipetted into 1.5 mL Eppendorfs in 1 mL fractions.

Protein Storage. (Time Allocation: 5 minutes) For storage, protein samples were flash frozen in
liquid nitrogen. Transformed cell stocks were mixed with glycerol, creating a 20% glycerol final
concentration then flash frozen in liquid nitrogen as well. When not in use, all protein and cell
aliquots were stored at -80°C. A. Thaliana plant matter was stored at -80°C until extraction. A.
thaliana extract was dissolved in a 20% glycerol solution and flash frozen in liquid nitrogen and
stored at -80°C.

Fast Protein Liquid Chromatography (FPLC)
Gradient IMAC Purification. (Time Allocation: 4 hours, done in the Antos lab) After HIC or IMAC
purification, some proteins required further purification. If they included a His tag, they were
further purified via FPLC on a Biorad NGC Chromatography System Quest 10 Plus using a 5 mL NiNTA column. 20% ethanol, ddH2O, Tris IMAC Wash Buffer and Tris IMAC Elution Buffer were used
for the gradient elution described in the automated program named “Affinity IMACFeb
2020_1.5mLfrac_5mL_loop” in ChromLab 4.0. Prior to FPLC, the instrument was flushed with ~5
CVs of ddH2O. The automated program rinsed the column with 3 CVs of Tris IMAC Wash Buffer
followed by sample injection. After injection, the column was washed with 3 CVs of Tris IMAC
Wash Buffer, followed by a linear gradient from 0% to 100% of Tris IMAC Elution buffer over 5
CVs. Finally, the column was rinsed with 5 CVs of Tris IMAC Wash Buffer. All automation was
performed at a flowrate of 5 mL/min. After the ChromeLab automation finished, the instrument
was manually instructed to be flushed with ~5 CVs of ddH2O and then ~5 CVs 20% ethanol in
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which it was stored. Samples were buffer exchanged into Tris IMAC Lysis Buffer, spin
concentrated to 5 mL or less, and 0.22 µm filtered directly prior to injection into the FPLC system.

FPLC Elution Purity Characterization. (Time Allocation: 2 hours) After FPLC, the A280 absorbance
peaks recorded on the ChromLab software were used to determine which fractions likely
contained pure protein. The elutions selected were characterized via SDS-PAGE using the
“Running Gel Electrophoresis” protocol from the Materials and Methods section of this thesis.
Samples from lanes determined pure by SDS-PAGE were then further characterized with “Protein
Characterization with Mass Spectrometry” protocol found below.

Liquid Chromatography Electrospray Ionization Mass Spectrometry (LC-ESI-MS)
Protein Characterization with Mass Spectrometry. (Time Allocation: 1 hour) LC-ESI-MS of
purified proteins was performed using an Advion Expression cmsL mass spectrometer interfaced
with a Dionex Ultimate 3000 HPLC system equipped with a Phenomenex Aeris 3.6 µm WIDEPORE
C4 200 Å column (100 X 2.1 mm). In general, 50 µL of protein solution in aqueous buffer was
loaded into an HPLC vial and diluted with 50 µL of ddH2O. Separations upstream of the mass
spectrometer were achieved using a gradient elution with an aqueous (95% H2O, 5% MeCN, 0.1%
formic acid) and organic (100% MeCN, 0.1% formic acid) mobile phase (0.3 mL/min, method: 10%
organic from 0.0-1.0 min, linear gradient of 10-90% organic from 1.0-7.0 min, 90% organic from
7.0-9.0 min, linear gradient of 90-10% organic from 9.0-9.1 min, re-equilibration at 10% organic
from 9.1-12.0 min). Protein charge ladder deconvolution was performed using Advion Data
Express software.

Sortase Mediated Ligation Data Analysis
Mass Spectrometry Data Analysis. (Time Allocation: 3 hours per data set, done in the Antos lab)
Sortase mediated ligation data was compiled with Analyst 1.4.2 and then processed using
Microsoft Office 365 Excel. Exported data from Analyst 1.4.2 included the intensity (c/s) of
unmodified protein (UP), ligation product (LP), expected hydrolysis products (HP), and expected
intramolecular products (IP). Percent ligation at each time point was calculated using the
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following equation: Percent ligation = (UP+HP+LP+IP) ∗ 100%. Ligations were performed in
triplicate and averaged using the Excel equation “=AVERAGE()”. Standard deviation was
determined with the equation “=STDEV.S()”.

Protein Database
Organization. A database was created in Excel (located on the Smirnov Google Drive with the xlsx
file name “Protein Database”) to track protein samples, transformed cells and plasmids’ location
and their properties. Three Excel tabs were made for each native protein type (villin-4, dematin,
and SML constructs).

Arabidopsis Thaliana Plant Growth
Media Preparation. (Time Allocation: 1.5 hours) Four, 1 L flasks were prepared with 500 mL of
0.5X Murasighe and Skoog Media and 2% sucrose each, and pH balanced to a pH of 5.7, then
autoclaved. (Sucrose promotes root growth and inhibits shoot growth. This is because the sucrose
tricks the plant into believing it is photosynthesizing well)

Seed Coat Sterilization. (Time Allocation: 1 hour) In an Eppendorf, one scoop (~30 µL) of wildtype A. thaliana seeds was suspended in ~1 mL of Seed Sterilization Solution for 20 minutes.
Three more Eppendorfs were prepared in this way for a total of four suspensions in Eppendorfs.
The Seed Sterilization Solution was decanted, and the seeds were each rinsed 5-7 times with 1
mL additions of sterile ddH2O, with decanting between each addition. The seeds were then
suspended in 1 mL of sterile ddH2O and quickly pipetted into a Murasighe and Skoog Media flask
(1 Eppendorf per flask) before the suspension settled. The seeds were grown for 10 days, shaking
at 80-90 rpm under fluorescent growth lights. All work was performed in sterile conditions in a
laminar flow or biosafety hood.

A. thaliana Freezer Storage. (Time Allocation: 30 minutes) Sanitary conditions is not necessary
for this protocol. The largest mortar available was filled with liquid nitrogen. The pestle was
placed in the liquid nitrogen to chill with the mortar. As the mortar and pestle chilled, the A.
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thaliana plant mass was removed from the Murasighe and Skoog Media and allowed to drip dry.
Once the dripping slowed considerably, the plant mass was dried by gently squeezing between
paper towels. (The goal was to dry the plant as thoroughly as possible, while not rupturing the
plant cells). After drying, the plant mass was transferred to the mortar (about ½ of the mortar
volume) and enough liquid nitrogen was added to submerge the plant. As the plant mass froze,
a flacon tube (large enough for storing the plant material) was filled with liquid nitrogen.
Following this, using the frozen mortar and pestle, the plant mass was gently broken down (the
goal is to not rupture cells, merely decrease the volume of the plant material) then transferred to
the liquid nitrogen-containing flacon tube. The tube was capped after all the liquid nitrogen had
evaporated. The ground A. thaliana was stored at -80°C.
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Chapter III – Results and Discussion
Aim 1: Plant Villin 4 Sequence Analysis
Villin 4 Homologs. Villin-4 contains structural homology between vertebrate villin and human
dematin. Villin-4, vertebrate villin and dematin contain actin-binding, C-terminal folded
headpiece domains. Recently, our lab discovered the disordered linker of villin-4 binds actin,
similarly to dematin as shown in figure 3.1. However, overall VLN4’s structure more closely
resembles that of vertebrate villin. Analysis of the similarities and differences between VLN4 and
its better studied homologs could present valuable information, aiding in the identification and
characterization of potential sites of modification.

Figure 3.1. Structural domain alignment of plant villin 4, vertebrate villin and human dematin.

Villin 4 Sequence Analysis. The program PhosIDP predicted highly charged and opposing-valued
stretches within the disordered linker region and experimentally determined folded headpiece
of villin 4 (Figure 3.2(b)). Due to the predicted fold propensity (Figure 3.2(c)), (where yellow
peaks are ordered and blue peaks are disordered, with greater amplitude indicating higher levels
of order or disorder respectively), the opposing-charged regions could participate in binding
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interfaces with each other. Within the disordered linker region of villin 4 there were four
instances identified by PhosIDP around amino acid residues 800 to 850 where fold propensity
changed from negative to positive values. The surrounding residues contained relatively small
fold propensity values indicating a high probability of ordered transient structures. For these
reasons, I propose the positively charged region (~800aa-850aa) creates a binding interface with
negatively charged filamentous actin and requires further inquiry into its potential regulation.

a
b

c

d
Figure 3.2. Structural alignment of charge and fold propensity and phosphorylation sites of plant
villin 4. Data compiled by PhosIDP.34 (a) Structural representation of the protein villin 4 where
the linker is positioned between the core and headpiece. (b) Displays net charge of villin 4 aligned
with its structure in (a) per residue calculated over a sliding, overlapping 21 amino acid window.
The dark blue and red colors represent the positive and negative charge scores per amino acid
before phosphorylation. Changes to the net charge upon phosphorylation are depicted in light
blue and red shades. The green and pink lines tracking the charge profile are for
unphosphorylated and phosphorylated values respectively. (c) Displays fold propensity per
residue calculated over a sliding, overlapping 21 amino acid window. The dark yellow and blue
colors respectively represent the positive and negative fold propensity scores per amino acid
before phosphorylation. Changes to the fold propensity upon phosphorylation are shown in light
yellow and blue shades. An additional sawtooth window is included to smooth structured and
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intrinsically disordered regions displayed on the plot. The green and pink lines tracking the fold
propensity profile are for unphosphorylated and phosphorylated values, respectively. PhosIDP
predicted a region within the headpiece of VLN4 as having a relatively equal fold propensity to
regions within the disordered linker. Since the headpiece was experimentally determined to be
ordered, this prediction should be approached with caution regarding other regions’ fold
predictions. (d) Displays the location of predicted phosphorylation sites in the sequence.
Phosphoserine is shown in blue (residues 777, 787, and 890), phosphothreonine in green (no
sites found), and phosphotyrosine in orange (no sites found).

Figure 3.2(b) shows PhosIDP’s predicted windowed charges of VLN4 before and after
phosphorylation. The charges before and after phosphorylation are indicated in green and pink,
respectively. After phosphorylation, the residues on the N-term side of the predicted ordered
region in the linker (~775aa-800aa) are seen to drastically become less positive, some residues
are even seen as negative charge predictions. Additionally, after phosphorylation, the residues
on the C-term side of the predicted ordered region within the disordered linker (~890aa-900aa)
are seen to become more negative in charge. These changes in charge surrounding the predicted
ordered region present a unique story regarding the regulation of VLN4 actin binding activity.
Upon phosphorylation, villin 3 was shown to no longer bind actin. 35 Hence, I hypothesize the
residues predicted to increase in negativity upon phosphorylation aid in regulative dissociation
of VLN4 from actin. This could likely be due to the swap of the potential charge-charge
interactions between the residues surrounding the predicted ordered region (~800aa-850aa) and
actin.

Vertebrate Villin Sequence Analysis. Similar to the analysis of plant villin 4, vertebrate villin 1
(from Gallus gallus, chicken) (another regulator of actin) was analyzed using PhosIDP.36 The
analysis predicted almost the entirety of the disordered linker to be negatively charged with two
transient, positively charged segments (at residues ~700 and ~740) (Figure 3.3(b)). These
segments align with two predicted folded segments within the disordered linker (Figure 3.3(c))
much like PhosIDP’s prediction of VLN4. However, the disordered region of vertebrate villin
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shows no predicted phosphorylation sites, the linker is mostly folded, and is almost entirely
negative in charge. For these reasons we currently believe that although the structure of
vertebrate villin is strikingly similar to VLN4, it is just a linker and does not participate in actin
binding/bundling.

a
b

c

d
Figure 3.3. Structural alignment of charge and fold propensity and phosphorylation sites in
vertebrate villin 1 (from Gallus gallus, chicken). Data compiled by PhosIDP.34 (a) Structural
representation of the protein vertebrate villin 1 where the linker IDR is positioned between the
core and headpiece. (b) Displays net charge of vertebrate villin 1 aligned with its structure in (a)
per residue calculated over a sliding, overlapping 21 amino acid window. The dark blue and red
colors represent the positive and negative charge scores per amino acid before phosphorylation.
Changes to the net charge upon phosphorylation are depicted in light blue and red shades. The
green and pink lines tracking the charge profile are for unphosphorylated and phosphorylated
values respectively. (c) Displays fold propensity per residue calculated over a sliding, overlapping
21 amino acid window. The dark yellow and blue colors represent the positive and negative fold
propensity scores per amino acid before phosphorylation. Changes to the fold propensity upon
phosphorylation are shown in light yellow and blue shades. An additional sawtooth window is
included to smooth structured and intrinsically disordered regions displayed on the plot. The
green and pink lines tracking the fold propensity profile are for unphosphorylated and
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phosphorylated values respectively. (d) Displays the location of phosphorylation sites in the
sequence. No phosphorylation sites were found.

a

c

b

Figure 3.4. (a) Aggregated data of predicted disorder in plant villin 4 headpiece and its linker IDR
and human dematin C-terminal headpiece and partial IDR by disorder prediction software
PONDR. Percent predicted disordered was calculated by the percent of algorithms which
predicted disorder with greater than 50% probability. Algorithms’ unaggregated PONDR scores
for villin-4 (b) and dematin (c).

Disorder Predictions. Across software, predicted protein structures can vary. To obtain a better
understanding of this variety an aggregative protein disorder prediction software called Disorder
Enhanced Phosphorylation Predictor (PONDR) was used to present cumulative predictions crossalgorithm. To do this, percent predicted disorder was calculated for each residue across five
different prediction techniques (VSL2, VL3, VL-XT, XL1-XT, Can-XT) by cumulatively adding
predictions with greater than 50% certainty. This analysis supports the hypothesis of small

27

ordered regions within the disordered linker of VLN4 (Figure 3.4(a,b)), but also reveals the
continued need for further in vitro analysis given the wide variability. Compared to human
dematin (Figure 3.4(c)) (another actin binding protein), the headpiece and IDR of VLN4 contain
similar predicted regional stretches of order and disorder.

Villin 4 Predicted Sites of Modification. Within the disordered 191 residue linker of villin-4, three
sites were predicted by PhosIDP to undergo phosphorylation by phosphoserine and five residues
for ubiquitination (Figure 3.5).37 These sites were examined for covalent medication in the VLN4
fragment sVL191h.

Figure 3.5. Amino acid sequence of VLN4 fragment construct sVL191h, containing the full linker
of villin-4. Resides in blue were predicted by both Disorder Enhanced Phosphorylation Predictor
(DEPP) and phosIDP to potentially undergo phosphorylation. Residues highlighted in yellow were
predicted by Prediction of Ubiquitination sites with Bayesian Discriminant Method (BDM-PUB)
using the high “specificity” performance selection to become ubiquitinated.

Aim 1: Villin 4 and A. thaliana Extract Exposure
Linker Residues of VLN4 Promote Degradation. To explore potential VLN4 covalent
modifications, multiple fragments containing different regions of VLN4 were incubated in A.
thaliana plant extract. The fragments analyzed ranged from just the C-terminal headpiece to the
full disordered linker (Figure 3.6). Controls included protein construct extract exposure in the

28

presence of protease inhibitor and plant extract exposure of cleaved relevant affinity protein
tags.

a

b

c

Figure 3.6. Schematic of amino acid sequences of VLN4 fragments (a) atVHP63srt, (b) atVHP164,
and (c) sVL191h used in the A. thaliana plant extract trials. Methionine is included on the N-term
of sVL191h’s sequence to denote its presence in the protein expression.

Villin 4 Headpiece. The headpiece of VLN4 was probed for modification using the protein
construct which consisted of A. thaliana villin headpiece including 63 residues from the native Cterminus followed by a double glycine residue spacer (spacer adds flexibility and allows for
sortase mediated ligation), a TEV cleavage site, followed by a His6 affinity tag (atVHP63srt).
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The representative SDS-PAGE (Figure 3.7) supports the stability of VLN4’s folded headpiece
domain to proteolytic degradation. In control lanes 2 and 3 the protein bands at ~10 kDa pertain
to the experimental protein atVHP63srt diluted in PIPES buffer (the buffer A. thaliana extract is
in). These lanes show no modification of atVHP63srt over 24 hours at room temperature. Control
lanes 4 and 5 consist of A. thaliana extract diluted with IMAC elution buffer (the buffer
atVHP63srt is in). These lanes show no modification of A. thaliana extract over 24 hours at room
temperature. Finally, experimental lanes 6-8 consist of atVHP63srt in A. thaliana extract. These
were loaded onto the gel 0 hours, 24 hours, and 1.5 hours respectively after mixed. These lanes
show no modification of atVHP63srt after 24 hours. This result was repeatable (Appendix II,
atVHP63srt Gels), thus I conclude the folded C-terminal headpiece domain of VLN4 does not
contain residues susceptible to proteolysis in A. thaliana extract.

Figure 3.7. 15% SDS-PAGE of the exposure of atVHP63srt to A. thaliana plant extract over 24
hours. Yellow arrows indicate experimental protein.
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Villin 4 Headpiece and Partial Disordered Linker. Similar to atVHP63srt, another protein
construct was tested for covalent modification. The protein atVHP164 consisted of VLN4’s full
headpiece and 101 residues of the disordered linker, nomenclatures as follows: “at” (A. thaliana),
“VHP” (villin headpiece), “164” residues from the native C-term of VLN4.

In figure 3.8 control lanes 3 and 4 show no modification of the experimental protein atVHP164
over 24 hours. Since A. thaliana plant extract had been repeatably shown to be stable over 24
hours, a single lane of plant extract was provided as a control (lane 5). In experimental lanes 6-8
atVHP164 was exposed to A. thaliana plant extract for 0 hours, 1.5 hours, and 24 hours
respectively. After 1.5 hours of exposure little to no modification of the atVHP164 band was seen.
However, in lane 8, after 24 hours the atVHP164 band was seen to have a significant decrease in
intensity. This result was reproduced multiple times (Appendix II, atVHP164 Gels). When
contrasted with trials from the plant exposure of folded headpiece atVHP63srt, the results
suggest that proteolytic sites are present within the disordered linker and promote degradation.

Figure 3.8. 15% SDS-PAGE of the exposure of atVHP164 in A. thaliana plant extract over 24 hours.
Yellow arrows indicate experimental protein.
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Villin 4 Affinity Tags. To determine what extent the affinity purification tags may have affected
the degradation of the VLN4 constructs, various exposure trials were performed on cleaved
affinity tags. The affinity tags were cleaved via a TEV protease digestion of the protein constructs.

Figure 3.9 shows the plant extract exposure of FH8 tag (derived from TEV cleaved atVHP164).
Control Lanes 2 and 3 showed no change in band intensity to FH8 over 24 hours. Control lanes 4
and 5 also showed no change to the A. thaliana plant extract over 24 hours. Experimental lanes
6-8 revealed slow modification of the cleaved FH8 tag over 24 hours.

Figure 3.9. 15% SDS-PAGE of the exposure of FH8 in A. thaliana plant extract over 24 hours.
Yellow arrows indicate experimental protein.

Villin 4 Full Disordered Linker. After discovering the degradation of a fragment of VLN4
containing the headpiece and partial disordered linker, the full disordered linker of VLN4 was
examined. The full disordered linker construct was named sVL191h. “s” refers to the strep tag on
the N-terminus followed by all 191 residues of the villin linker (“VL”). Finally, on the C-term is a
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His8 tag to provide an additional method of purification as well as protection from degradation.
The exposure trials were performed in a similar manner as before. Control lanes 2 and 3 of the
resulting SDS-PAGE gel (Figure 3.10) contained protein construct sVL191h and solvated in PIPES
buffer and showed no modification of sVL191h after 24 hours on the benchtop. Control lanes 4
and 5 contained A. thaliana plant extract diluted with strep elution buffer and reaffirm no change
in A. thaliana plant extract over 24 hours on the benchtop. Finally, experimental lanes 6-8
consisted of the VLN4 disordered linker construct sVL191h and A. thaliana plant extract at time
points 0 hours, 24 hours, and 1.5 hours after exposure. In lane 7, the sVL191h band was shown
to disappear (contrasted with lane 6). Furthermore, in lane 8, after 1.5 hours the sVL191h band
was also completely diminished. These results revealed the disordered linker of VLN4 to be highly
modified in A. thaliana plant extract. These results could not be due to the include His8 tag, as
histidine tags had already been shown not to promote degradation via the atVHP63srt in A.
thaliana extract trials.

Figure 3.10. 15% SDS-PAGE of the exposure of sVL191h in A. thaliana cell extract over 24 hours.
Yellow arrows indicate experimental protein.

To further explore the remarkable time-sensitivity of the degradation of sVL191h, an additional
trial was performed following the same setup as figure 3.10 but instead examining time-points
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between 0 hours and 1.5 hours. The folded headpiece construct (HP63srt) was included in this
SDS-PAGE (Figure 3.11) as additional controls at 0 hours and 24 hours (lanes 9 and 10,
respectively). The headpiece control showed no degradation over 24 hours. Control lane 2
contained sVL191h and PIPES buffer. Control lane 3 contained A. thaliana plant extract and strep
elution buffer (the buffer sVL191h was in). Experimental lanes 4-8 consisted of VLN4 disordered
linker construct sVL191h and A. thaliana plant extract at time-points 0 hours, 5 minutes, 15
minutes, 30 minutes, and 1.5 hours, respectively. In Lane 4, it is noteworthy that in the time it
took to load the gel, additional bands (at ~20 kDa) indicating the modification of sVL191h have
already appeared. After 5 minutes (lane 5) most of sVL191h had been modified and distinct bands
at ~20 kDa and ~13 kDa became visible. After 15 minutes (lane 6) the sVL191h band had
completely disappeared. You may note the A. thaliana plant extract appears less concentrated
compared to previous plant exposure trials. This was intentional as to better observe any
potential protein fragments created by proteases.

Figure 3.11. 15% SDS-PAGE of the exposure of sVL191h in A. thaliana plant extract over 1.5 hours.
Yellow arrows indicate experimental protein.

Given the high levels of modification observed in sVL191h, the VLN4 disordered linker construct
was exposed to A. thaliana plant extract with protease inhibitor PMSF. This was done to
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determine if proteases were the cause of sVL191h’s modification. Compared to trials without
PMSF, the resulting SDS-PAGE (Figure 3.12) revealed 3X more exposure time was required to
completely modify sVL191h.

Figure 3.12. 15% SDS-PAGE of sVL191h exposure to A. thaliana plant extract over 1.5 hours in 1
mM PMSF with DMSO controls. Yellow arrows indicate experimental protein.

To further explore this trend, 100 mM PMSF trials were conducted (Figure 3.13). However, as
PMSF is not soluble in water, the hyper-saturated PMSF in DMSO solution crashed out once it
was added to the aqueous solution. To account for PMSF crashing out, extra care was taken to
ensure PSMF was thoroughly suspended before pipetting. Although the PMSF-sVL191h-extract
solution was not truly 100 mM PMSF, this reaction still saw more than 6X the time required to
completely modify sVL191h over that of the non-PMSF trial. These findings were repeatable
(Appendix II, sVL191h Gels) and suggest proteases are responsible for the degradation of
sVL191h. However, to affirm this, further PMSF control trials will need to be repeated with a
control for DMSO at a shorter time point than 1.5 hours. To do this, I suggest repeating this
experiment but with a 30-minute control lane replacing lane 10 in figure 3.13.

35

Figure 3.13. 15% SDS-PAGE of the exposure of sVL191h in A. thaliana plant extract over 1.5 hours
in 100 mM PMSF with DMSO controls. Yellow arrows indicate experimental protein.

Villin 4 Purification After Exposure to A. thaliana Extract. To characterize potential VLN4 protein
fragments following A. thaliana exposure, methodologies to purify sVL191h from A. thaliana
extracted were created. sVL191h was purified with affinity chromatography using Strep-Tactin
resin, producing the image seen in figure 3.14. Control lanes 2, 3 and 4 were used as standards
for sVL191h, A. thaliana extract, and the exposure of the two which was loaded on the column,
respectively. Lane 4 showed complete degradation of sVL191h and the presence of bands at ~12
kDa and ~17 kDa which were not present in the sVL191h and A. thaliana extract controls in lanes
2 and 3. Given the molecular weights of the bands, these likely are fragments of sVL191h. The
degradation shown was expected due to sVL191h’s degradation time trials in A. thaliana extract.
Experimental Lane 5 shows the flow-through of the Strep-Tactin resin. The fragments of sVL191h
at ~17 kDa are greater in intensity than the expectant sVL191h fragments at ~12 kDa, providing
evidence that the bands at 12 kDa contained active Strep-Tactin binding domains. Given this, the
12 kDa fragments are likely N-terminal, provided their reappearance in elutions 2 and 3 (lanes 9
and 10 respectively) along with Strep affinity domain-containing full sVL191h VLN4 linker at ~28
kDa and the notable absence of the bands at ~17 kDa.
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Figure 3.14. 15% SDS-PAGE of a Strep-Tactin resin purification of the exposure of sVL191h in A.
thaliana plant extract at 0 hours. Yellow arrows indicate experimental protein.

Villin 4 Conclusion. Residue(s) within the disordered linker of VLN4 were shown to be responsible
for covalent modification. This was exemplified by the folded headpiece and subsequent IDRcontaining protein construct’s SDS-PAGE. Constructs which contained larger regions of the
disordered linker, showed increased degradation when exposed to A. thaliana plant extract.

The data provides substantial evidence to support specific residues being targeted for proteolysis
within the disordered linker of VLN4. Throughout the SDS-PAGE gels of sVL191h trials (Figures
3.11-3.14), two bands at ~12 kDa are clearly visible. By analyzing sVL191h’s sequence there are
two predicted residues susceptible to proteolysis from 10-15 kDa from the N-terminal.

Future Villin 4 Work: To provide greater scientific certainty that protease inhibitor PMSF is the
primary cause of reduced proteolytic activity in disordered VLN4 linker construct sVL191h, DMSO
controls need to be performed at timepoints where sVL191h was shown to degrade without
PMSF (example: 10 minutes). Furthermore, performing more proteolysis inhibition trials with a
protease inhibitor “cocktail” or in the presence of urea may be beneficial to determining their
utility as additives in affinity chromatography buffers. For future proteolytic analyses it is
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imperative to quench the degradation of sVL191h during column chromatography, as it opens
many doors for future analysis of potentially time-sensitive fragments. Another avenue that may
aid the solubility and time-sensitivity complications may be to optimize (by minimizing) the A.
thaliana extract concentration for degradation trials.

Aim 2: Sortase Mediated Ligation Construct Design and Production
LPXTG Flanking Region Amino Acid Residue Properties. Six potentially problematic extreme
flanking amino acid residue scenarios were examined to determine the extent of their impact on
ligation efficiency. The scenarios tested include: proline, aromatic, acidic, basic, bulky aliphatic,
and polar charged rich flanking regions on the C-term and N-term sides of the LPXTG ligation site.
I named the constructs based on these properties as follows: proline N-terminal (ProN), proline
C-terminal (ProC), aromatic N-terminal (AroN), aromatic C-terminal (AroC), acidic N-terminal
(AcidN), , acidic C-terminal (AcidC), basic N-terminal (BasN), basic C-terminal (BasC), aliphatic Nterminal (AliN), aliphatic C-terminal (AliC), polar N-terminal (PolN), polar C-terminal (PolC), and
GGGGG control.

Sortase Mediated Ligation Construct Production. Expression and purification techniques of the
SML constructs were optimized. This included plasmid transformation times, E. coli growth times,
IPTG induction times, lysing protocols and affinity chromatography techniques. I produced
constructs: proline N-terminal, acidic N-terminal, acidic C-terminal, basic N-terminal, basic Cterminal, aliphatic N-terminal, aliphatic C-terminal, polar N-terminal, polar C-terminal, and
GGGGG control (table 3.1).
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Table 3.1. Scenarios of extreme flanking sortase mediated ligation constructs that were
characterized for their compatibility with sortase mediated ligation. Bold residues denote
experimental residues and red residues indicate single residue mutations from native residues to
LPXTG ligation sequences.

Ni-NTA resin gravity affinity column chromatography was performed utilizing the 6xHis affinity
on the constructs (Figure 3.15(b)) on all of the SML constructs. However, some constructs such
as BasN required further purification (Figure 3.16). Initially, gravity hydrophobic interaction
chromatography (utilizing the included FH8 affinity tag on the constructs) was performed on
impure constructs (Figure 3.17). This was shown to improve the impurity, but bands of specific
molecular weights remained.

39

a

b

Figure 3.15. (a) Scheme of SML constructs after ligation with their respective peptide. (b) An
example of a sortase mediated ligation construct (Proline N-terminal) sequence prior to ligation.

Figure 3.16. 15% SDS-PAGE of Ni-NTA resin gravity Immobilized Metal Affinity Chromatography
(IMAC) of protein construct BasN.
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Figure 3.17. 15% SDS-PAGE of gravity hydrophobic interaction chromatography of protein
construct BasN.

Problematic constructs were further purified via FPLC with Ni-NTA affinity resin (IMAC). As shown
in figure 3.18 two main UV-Vis peaks were typically identified during FPLC. The elutions
corresponding to the highest intensity peaks were preliminarily analyzed with SDS-PAGE (Figure
3.19). The gel identified elutions 35-40 contained the highest concentration of potential protein
construct BasN compared to other impurities. The identity of predicted BasN was then
quantitively confirmed via LC-ESI mass spectrometry (representative Figure 3.20). Elutions 35-40
of the FPLC purification were selected for Tris buffer exchange for ligation studies. Constructs
BasN, AliN, AliC, and AcidC required additional purification via the extended process described.
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Figure 3.18. ChromeLab’s chromatogram (280 nm) of FPLC Ni-NTA purification of BasN elutions
7-12 from figure 3.17.

Figure 3.19. 15% SDS-PAGE of protein construct BasN FPLC (Ni-NTA) elutions 27-44.
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Figure 3.20. Quantification of protein construct BasN identity and purity via LC-ESI mass
spectrometry. Mass spectrum of BasN elution 39 after FPLC with Ni-NTA resin seen in figures 3.18
and 3.19. At 11376.1 Da an acetonitrile adduct is visible. This expected peak is not present when
methanol is used for the mobile phase during ligation efficiency quantification.

Aim 2: Sortase Mediated Ligation Results
Sortase Mediated Ligation Data Analysis. After ligation of the constructs by undergraduate
student Micah Lund, the mass spectrometry data was exported into Analyst 1.4.2. The ligation
reaction’s mass spectrometry data over eight hours was processed using an excel spreadsheet I
created. Ligation was calculated as a percentage at each time point (taken once per hour) using
mass spec intensity values via the equation: =(Ligation product)/((Ligation product)+(Unmodified
protein)+(Hydrolysis product)+(Intramolecular product)). Each time point was averaged (total of
three trials) and standard deviations were calculated for each time point using the equation:
=STDEV.S((Percent ligation of trial 1),(Percent ligation of trial 2),(Percent ligation of trial 3)). I
personally processed the data of AroC and AroN.
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Percent Ligation at 8 Hours
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AcidN

BasN

PolN

PolC GGGGG

Figure 3.21. Comparison of ligation scenarios to their authentic polypeptide sequences. Light
blue indicates N-terminal scenarios, blue: C-terminal scenarios, gray: pentaglycine control. PolC
intentionally has no error bar. At the time of writing, there was only one, 8-hour ligation data
point of the PolC construct.

Sortase Mediated Ligation Results Analysis. As a control for a comparison to an optimal ligation,
construct GGGGG was ligated to a GGGGG-DNP peptide. This control showed near 80% ligation
after 8 hours, indicating that any constructs close to 80% ligation after 8 hours are efficient
sequences (Figure 3.21). At the time of writing, constructs AcidC, BasC, AliN, AliC, and PolC have
not been reported yet. Constructs ProN, ProC, AroN, AroC, AcidN, and PolN all performed
unexpectedly poorly with ligation efficiencies below 35%. The ligation of AroN was so low its
ligation product was indiscernible via mass spectrometry. PolC and BasN both performed above
50%, while BasN performed within the margin of error of GGGGG control.
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Percent Ligation at 8 Hours
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40%
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AroC - GGGGG

GGGGG - YYHWD

GGGGG - GGGGG

Figure 3.22. Comparison of the AroC constructs ligated to C- and N-terminal pentaglycine
controls. AroC - YYHWD: AroC protein ligated to its native YYHWD peptide, AroC - GGGGG: AroC
protein ligated to GGGGG control peptide, GGGGG - YYHWD: GGGGG control protein ligated to
native YYHWD peptide, GGGGG - GGGGG: GGGGG control protein ligated to GGGGG control
peptide.

Overall, it is evident that the properties of surrounding residues around the ligation site have an
exceptional impact on sortase enzyme’s ability to perform ligation. Notably, the data presented
reveals N-terminal characteristics may produce a greater impact on ligation efficiency than the
C-terminal flanking region around LPXTG. This is proposed due to all three constructs which have
C- and N-terminal data sets show the N-terminal scenarios to perform worse than their Cterminal counterparts. Given our minimal understanding of the sortase binding interface, I
propose there could be a greater degree of steric interaction between the N-terminal flanking
region of the ligated protein and the sortase enzyme than between the sortase enzyme and the
C-terminal flanking region. Contrarily, it is also possible the extreme nature of the N-terminal
constructs could interact with the nonpolar FH8 affinity tags, masking the ligation of N-terminal
scenarios.
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To further determine the efficiency of ligation scenarios, pentaglycine controls were coupled with
problematic native sequences (Figure 3.22). These trials further revealed the crucial nature of
the N-terminal flanking region of ligation sequences. When GGGGG was ligated to the AroC
peptide, there was over a four-fold increase in ligation efficiency, yet the efficiency still remains
low when compared to the pentaglycine control. Ligation data was gathered by Micah Lund, Liam
Quille.

Future Sortase Mediated Ligation Work: Additional constructs containing two glycine spacers
before the 5-residue extreme scenario flanking regions will be tested for their ligation efficiency.
This will be performed alongside their authentic ligation partners with two additional glycine
spacers. Furthermore, hepta-mutant sortase type A will be used as an alternative ligation
enzyme. In conjunction, these additional tests should provide more data and hopefully present
greater opportunities to elucidate trends in the extent of ligation as a function of ligation site
sequence context.
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Chapter IV – Conclusions and Discussion
Aim 1: Plant Villin 4 Conclusions
Villin 4 Covalent Modification. The work shown here was the first to discover proteolytic activity
within the disordered region of the plant protein A. thaliana villin 4 (VLN4). VLN4 was repeatably
characterized to possess two general regions within its disordered linker that promote
proteolytic activity. These findings provide ample evidence for further inquiry into specific
residue(s) responsible for the regulation of VLN4. In addition, methodologies were developed to
perform covalent modification on VLN4 fragments in A. thaliana extract, purify them back out of
A. thaliana extract, and store/handle their degrative products.

Through the use of terminal purification tags, VLN4 disordered linker fragment sVL191h’s
degrative products were able to be separated and purified. Separation and purity were
qualitatively determined via SDS-PAGE. However, preliminary mass spectrometry was unable to
quantitively determine the specific masses of purified degrative products. Further mass analysis
via higher resolution QTOF mass spectrometry should be able to resolve these fragments in the
near future. The methodologies produced here pave the way for future researchers to continue
this work and perform mass analyses with a higher resolution mass spectrometer to determine
specific sites of degradation, phosphorylation, and ubiquitination.

Villin 4 Findings Value to Greater Scientific Community. The findings that 1: the disordered linker
of VLN4 is covalently modified and 2: VLN4 linker covalent modification is likely caused by
proteolysis, aligns with previously determined literature. The high solvent accessibility of the
disordered linker in VLN4 allows for a greater chance for regulatory covalent modifications.11
Whether the modification(s) observed were caused solely by proteases is unknown. The
modification seen could be due to unidentified PEST motifs (calpain-mediated) within the linker
that were not predicted by the prediction tool we used. Within VLN4’s linker there exists sections
of amino acids with high P, E, S, and T character within the qualitatively determined cleaved
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regions. These PEST motifs could act as regulators for VLN4. Confirming their proteasomal activity
would add to the greater body of knowledge for known PEST motifs, bettering predictive models.
Furthermore, the methodological groundwork laid here aids in the furthering of possible avenues
to greater food security. Identification of regulatory residues, followed by the production of
genetically modified VLN4 in vivo could produce improved water uptake and soil water
retention.23,24

Aim 2: Sortase Mediated Ligation Conclusions
Flanking Region Specificity. Eight LPXTG sequences with potentially problematic flanking regions
surrounding their LPXTG site were probed for ligation efficiency. Methodology was established
for the production of the ligation constructs. Various purification techniques were explored for
the purification of the constructs. IMAC with Ni-NTA resin was determined to be the best for
purifying the proteins, followed by FPLC using a Ni-NTA resin column.

Ligations were performed between the constructs and their respective peptides, using wild type
sortase A. Ligation efficiencies were determined based on the relative intensities of the expectant
ligation product and unmodified protein mass spectra peaks. Using this method, we determined
proline N and C-terminal, aromatic N and C-terminal, acidic N-terminal, and polar N-terminal
flanking region character to be detrimental to ligation efficiency at room temperature. Notably,
basic N-terminal character was shown to undergo ligation with high ligation efficiency
comparable to the control ligation.

As of now it is premature to discern patterns from the data available. However, it is remarkable
that of the C and N-terminal ligations where both were reported for the same scenario (example:
ProN and ProC), the C-terminal construct always performed better. This suggests that the Nterminal flanking regions may have a greater impact on ligation efficiency than that of the Cterminal flanking region. This was further exemplified in figure 3.22 where the N-terminal region
was exchanged for a glycine control, it performed better than when the native N-terminal
construct was paired with a C-terminal pentaglycine peptide.
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Sortase Mediated Ligation Findings Value to Greater Scientific Community. Provided that this
research is still very much underway, much of the value to the scientific community has still yet
to become made known. As of now, discernable patterns are not yet ready for dissemination.
However, the creation of general guidelines such as reaction times, temperatures, and their
optimum sortase type pairings are certainly within reach.
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Research Aims
Aim 1: Create robust methods to isolate plant protein villin-4 fragments (including its disordered
linker) from plant cell extracts and characterize the covalent modifications of the fragments with
mass spectrometry.

Aim 2: Characterize the reactivity of sortase mediated ligation sites within representative,
authentic intrinsically disordered region sequences and provide guidelines for optimization of
reaction conditions.
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Appendix I – Recipes Used
*NaOH and HCl was used to pH balance.
1 Liter Solution

0.22 μm filtered

1 Liter Solution

PIPES Buffer, (pH 6.8)
Component

0.22 μm filtered

MES Buffer, (pH 6.0)

Amount

Component

Amount

20 mM PIPES

6.05

g

20 mM MES

3.90

g

50 mM NaCl

2.92

g

200 mM NaCl

11.69

g

20 mL Solution

1 Liter Solution

Cell Cracking Buffer, (pH NA)
Component

0.22 μm filtered

IMAC Lysis Buffer, (pH 8.0)

Amount

Component

Amount

DTT

19.2

mL

300 mM NaCl

17.53

g

Urea

9.60

g

10 mM Imidazole

0.68

g

SDS

1.00

g

50 mM NaH PO

6.00

g

1M Tris HCl pH 6.8

0.80

mL

Bromophenol Blue

0.008

g

1 Liter Solution

2

0.22 μm filtered

1 Liter Solution

IMAC Wash Buffer, (pH 8.0)
Component
300 mM NaCl
50 mM NaH PO
2

4

20 mM Imidazole

4

0.22 μm filtered

IMAC Elution Buffer, (pH 8.0)

Amount

Component

17.53

g

300 mM NaCl

6.00

g

50 mM NaH PO

1.36

g

250 mM Imidazole

2
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4

Amount
17.53

g

6.00

g

17.02

g

1 Liter Solution

0.22 μm filtered

1 Liter Solution

FH8 Binding Buffer, (pH 7.6)
Component

0.22 μm filtered

FH8 Elution Buffer, (pH 10)

Amount

Component

Amount

50 mM Tris

6.06

g

50 mM Tris

6.06

g

150 mM NaCl

8.77

g

150 mM NaCl

8.77

g

5 mM CaCl

0.55

g

5 mM EDTA

1.46

g

2

1 Liter Solution

0.22 μm filtered

5 Liter Solution

FH8 Wash Buffer, (pH 7.6)
Component

SDS Running Buffer, (pH NA)

Amount

Component

Amount

25 mM Tris

3.03

g

Nanopure water

4950

75 mM NaCl

4.38

g

0.1% SDS

50.0 mL of 10% SDS
or 5 g

0.28

g

25 mM Tris

15.14

g

192 mM Glycine

72.10

g

2.5 mM CaCl

2

20 mL Solution

mL

20 mL Solution

Kanamycin, (pH NA)
Component

IPTG, (pH NA)

Amount

Component

Amount

Nanopure water

20.0

mL

Nanopure water

20.0

mL

10 mg/mL Kanamycin

0.20

g

0.8 M IPTG

3.81

g

1 Liter Solution

0.22 μm filtered

1 Liter Solution

Cleaning Wash Buffer, (pH NA)
Component

Solubilizing Buffer, (pH 7.5)

Amount

Component

Amount

0.5 M NaOH

20.00

g

8.0 M Urea

480.45 g

150 mM NaCl

8.77

g

25 mM DTT

3.86

g

50 mM Tris HCl

6.06

g
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1 Liter Solution

1 Liter Solution

Destaining Solution, (pH NA)
Component

Staining Solution, (pH NA)

Amount

Component

Amount

Nanopure water

650.0

mL

Nanopure water

45.0

mL

Ethanol

250.0

mL

Ethanol

45.0

mL

Glacial Acetic Acid

100.0

mL

Glacial Acetic Acid

10.0

mL

Coomassie BB R250

0.25

g

100 mL Solution

0.22 μm filtered

100 mL Solution

Low Salt Buffer, (pH 7.5)
Component

0.22 μm filtered

High Salt Buffer, (pH 7.5)

Amount

Component

Amount

25 mM HEPES

0.60

g

500 mM NaCl

2.92

g

100 mM DTT

1.54

g

25 mM HEPES

0.60

g

Nanopure water

100.0 mL

100 mM DTT

1.54

g

Nanopure water

100.0 mL

1 Liter Solution

0.22 μm filtered

1 Liter Solution

0.22 μm filtered

Tris IMAC Wash Buffer, (pH 7.6)

Tris IMAC Lysis Buffer, (pH 7.6)

Component

Component

Amount

Amount

50 mM Tris

6.06

g

50 mM Tris

6.06

g

150 mM NaCl

8.77

g

150 mM NaCl

8.77

g

20 mM Imidazole

1.36

g

1 Liter Solution

0.22 μm filtered

5.00 mL Solution

Tris IMAC Elution Buffer, (pH 7.6)
Component

APS, (pH NA)

Amount

Component

Amount

50 mM Tris

6.06

g

10% APS

0.50

g

150 mM NaCl

8.77

g

Nanopure water

5.00

mL

300 mM Imidazole

20.42 g
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200 mL Solution

200 mL Solution

Seed Sterilization Solution, (pH NA)
Component

Seed Drying Solution, (pH NA)

Amount

Component

Amount

Household Bleach

100

mL

Ethanol

140.0

mL

ddH2O

100

mL

ddH2O

60.0

mL

0.1% v/v Triton X-100

1

drop

0.1% v/v Triton X-100

1

drop

1 Liter Solution

0.22 μm filtered

1 Liter Solution

Murasighe and Skoog Media, (pH 5.7)
Component

NiSO (pH NA)
4

Amount

Murasighe and Skoog
Basal Medium

2.15

g

23 mM MES Sodium
Salt

0.50

g

58.5 mM Sucrose

20.00

g

Component

Amount

Nanopure water

1000

g

100 mM NiSO

15.48

g

4

2 Gels
Resolve (bottom)
Component

Stack (top)
Volume

Component

Volume

Resolving Solution

6.00

mL

Stacking Solution

2.64 mL

40% Acrylamide

3.76

mL

40% Acrylamide

0.62 mL

10% APS

100

μL

10% APS

33.2 μL

TEMED

15.0

μL

TEMED

5.0

58

μL

4 Gels
Resolve (bottom)
Component

Stack (top)
Volume

Component

Volume

Resolving Solution

12.1

mL

Stacking Solution

5.28 mL

40% Acrylamide

7.52

mL

40% Acrylamide

1.24 mL

10% APS

200

μL

10% APS

66.4 μL

TEMED

30.0

μL

TEMED

10.0 μL

Volume: 500 mL
Resolving Solution
Component

Stacking Solution
Volume

Component

Volume

Nanopure water

284.8 mL

Nanopure water

414.7 mL

1.5 M Tris (pH 8.8)

207.0 mL

1.0 M Tris (pH 6.8)

79.0

10% SDS

8.278 mL

10% SDS

6.321 mL

mL

*Grey components should be added last. These will polymerize the gel and are time sensitive.
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Appendix II – Protocols
Plasmid Transformation and Protein Expression
Plasmid Prep (first time only)
1. Centrifuge plasmid at 6000 x g for one minute.
2. Add 20 μL of nanopure water and vortex for one minute, then centrifuge at 6000 x g for 30
seconds.

Plasmid Transformation
1. Get two >1 mL eppendorf tubes and aliquot 50 μL of BL21 E. coli cells to each tube. (Put on
ice)
2. Add 1 μL of nanopure water to a BL21 aliquot. (This is a control)
3. Add 1 μL of plasmid to the other BL21 aliquot.
4. To mix, gently flick aliquots 4-5 times.
5. Incubate BL21 aliquots for 30 minutes at 4 C.
6. Heat-shock (42 C) the BL21 aliquots for 15 seconds, then chill in an ice bath for 2 minutes.
7. Add 500 μL of Recovery Medium to each BL21 aliquot and incubate for 45 minutes at 37 C,
shaking at 210 rpm.
8. In an additional Eppendorf, add 500 μL of Recovery Medium and 50 μL of nanopure water.
(This is another control)
o

o

o

Transformation Plate Growth
Expected Results
Eppendorf Contents

+Kan

-Kan

200 μL

200 μL

1. Pipette 200 μL from each eppendorf to warmed
(37 C) +Kan and -Kan plates (shown to the
left).
2. Incubate the plates overnight (14-16 hours) at
37 C upside down.
3. Once colonies are visible on the plates, parafilm
them and store at 4 C upside down.
o

Cells + Plasmid

Growth

Growth

o

Cells + Nanopure
water

No
Growth

Growth

Recovery Medium +
Nanopure water

No
Growth

No
Growth

o
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1L Solution

100 mL Solution

LB
Component

LB
Amount

Procedure

Amount

Nanopure
water

1000

mL

100

mL

Yeast Extract

5.00

g

0.50

g

Bactotryptone

10.00 g

1.00

g

1. Combine the components in an
erlenmeyer flask. (Do not add kanamycin
yet)
2. Autoclave the LB solutions for 35
minutes.
3. Once cooled to 55 C, add the kanamycin.
o

NaCl
Kanamycin

10.00 g

1.00

1.00 mL of 10
mg/mL

g

0.10 mL of 10
mg/mL

Protein Expression
1. Prepare six, 1L flasks of LB and two 100 mL flasks of LB. (Recipes above)
2. Designate one transformed Plasmid Kan+ colony for each 100 mL flask of LB. Transfer the
colony to the flask by lighty dabbing it with a sterile pipette tip or stick, then swirl it into the LB.
3. Incubate the two 100 mL LB flasks in the shaker at 37°C, 210 rpm for 12-16 hours.
4. Collect a 1 mL sample from one of the 1L LB flasks. This will be used as a blank for the UV
spectrometer.
5. Add 25 mL from the 100 mL LB flasks to each of the six 1L LB flasks.
6. Incubate the six 1L LB flasks in the shaker at 37°C, 210 rpm until the optical density is between
0.5 and 0.6 abs at 600nm. (Check every 15-30 minutes, takes 2-4 hours)
7. Induce protein production by adding 1 mL of IPTG to each 1L LB flask. and continue the
incubation for 4-5 hours.
8. Centrifuge the contents of all six 1L LB flasks in centrifuge bottles for 30 minutes at 8,500 rpm
(12,785 RCF), 4 C.
9. Pour off the supernatant fluid and flash freeze the cell pellets in two, 50 mL falcon tubes with
liquid nitrogen. (3 growths per falcon tube)
10. Store at -20°C.
Protein Extraction
1. Resuspend the cell pellets in their falcon tubes in 30 mL of Lysis Buffer. (10 mL of Lysis Buffer
per 1L growth)
2. Add 30 µL of 50 mg/mL Lysozyme (10 µL Lysozyme per growth) to each falcon tube.
3. Parafilm the tubes and incubate at 4 C on a rotor for 30 minutes.
4. Sonicate the cells with two, 35 second pulses for each tube.
5. Add 30 µL of 10 units/µL DNase (10 µL per growth) to each falcon tube and invert tubes to mix.
6. Incubate the cells at room temperature on a rotor for 30 minutes.
7. Transfer falcon tube contents to centrifuge bottles and centrifuge at 18,400 rpm (40,000 RCF) for
30 minutes, 4 C.
o

o

o

Proceed to Relevant Purification
Water Soluble Protein
1. Filter supernatant with a 0.22 µm filter.
2. Perform column purification of the supernatant with the appropriate resin. (IMAC, size exclusion,
TALON, FH8) Resin protocols can be found in the Smirnov Google Drive at: Protocols → Resin
Columns
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Water Insoluble Protein
1. Pipette 1 mL of the growth into an eppendorf.
2. Spin down the growth for 5 minutes at 6,000 rpm (9,500 RCF).
3. Pour off the supernatant fluid and resuspend the cell pellet in cell cracking buffer via
vortexing.
4. Scrape the cell pellet against the inside of the eppendorf repeatedly. (~30 times)
5. Boil the eppendorf containing the cell pellet and cell cracking buffer for 10 minutes.
6. Repeat steps 4-5 twice (total of three times).

Purification with Ni-NTA Resin
Procedure
1. Pipette 3 mL of Ni-NTA resin into a resin column. (stored at 4oC)
2. Drain the ethanol from the Ni-NTA Resin.
3. Wash the column with two column volumes (CVs) of nanopure water.
4. Wash the column with two CVs of IMAC Lysis Buffer.
5. Add the cell lysate to the column, then cap and parafilm the column.
6. Equilibrate the column by shaking horizontally on a rotor at 4॰C for 30 minutes.
7. Collect the flow-through in an autoclaved falcon tube.
8. Wash the column with 4 CVs of IMAC Wash Buffer (with 1 mL additions, completely eluting
before the next addition) and collect in an autoclaved falcon tube.
9. Repeat step 8, two times. (total of 12 CVs)
10. Cap the column tip and add 1 mL of IMAC Elution Buffer, resuspend the resin, and wait 20-30
minutes to equilibrate.
11. Collect the elution in an autoclaved eppendorf tube.
12. Rinse the sides of the column with 1 mL of IMAC Elution Buffer.
13. Collect the elution in an autoclaved eppendorf tube.
14. Repeat steps 12-13, fourteen times. (total of fifteen, 1 mL fractions)
15. Recharge the resin according to the procedure Cleaning and Recharging Ni-NTA Resin below.
16. After five purifications, the resin needs to be regenerated according to the Regenerating Ni-NTA
Resin protocol below.

Purification with HIC Resin
Procedure
1. Pipette 8 mL of HIC resin to a column (stored at -20°C).
2. Wash the column with two column volumes (CVs) of nanopure water.
3. Wash the column with two CVs of FH8 Binding Buffer by thoroughly suspending the resin and
eluting.
4. Add the cell lysate and top off the column with FH8 Binding Buffer.
5. Parafilm the column and incubate at 4oC for 20 minutes.
6. Collect the flow-through in an Erlenmeyer flask.
7. Wash the column with a total of six CVs of FH8 Wash Buffer. Collect wash in three autoclaved
15 mL falcon tubes. (two CVs per falcon tube). Add 1 mL at a time and fully elute between
additions.
8. Equilibrate the column by suspending it in FH8 Elution Buffer. Wait ten minutes.
9. Elute the FH8 Elution Buffer into a 15 mL falcon tube (this is elution 1). Add 1 mL of FH8
Elution Buffer to the column and fully elute into an autoclaved Eppendorf (this is elution 2).
Repeat 1 mL additions of FH8 Elution Buffer for 15 elutions total.
10. Recharge the resin according to the procedure Recharging HIC Resin below.
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Regeneration of HIC Resin
Procedure
1. Rinse the resin with two BVs of FH8 Elution Buffer.
2. Rinse the resin with two BVs of nanopure water.
3. Rinse the resin with four BVs of 0.75 M NaOH.
4. Rinse the resin with three BVs of nanopure water.
5. Rinse the resin with four BVs of 30% isopropanol. (4-10)
6. Rinse the resin with three BVs of nanopure water.
7. Rinse the resin with two BVs of 20% ethanol.
8. Store the resin in 20% ethanol.

Purification with Strep Resin
Procedure
1. Pipette 1 mL of Strep-Tactin resin into a column (1 mL of resin per 1L growth). (stored at 4oC)
2. Drain the storage Strep Wash Buffer into a waste beaker.
3. Rinse the column with two BVs of Strep Wash Buffer.
4. Suspend the Strep-Tactin resin with cell lysate (maximum lysate volume of 10 BVs).
5. Wait for the resin to settle to the bottom of the column, then collect the flow-through in a falcon
tube.
6. Wash the column with 1 BV of Strep Wash Buffer using 1 mL additions and collect in a falcon
tube.
7. Repeat step 7, four times. (Total of 5 BVs)
8. Add 0.5 BVs of Strep Elution Buffer, and collect the elution in an Eppendorf.
9. Repeat step 9, 9 times. (Total of 5 BVs)
10. Regenerate the resin according to the procedure Regenerating Strep Resin below and store in
Strep Wash Buffer.

Note: FT and Washes take longer than IMAC or HIC (drips really slow) 4hr procedure for a
20 mL lysate
Collection Schematic
Fraction
Step Collection Buffer
1

2

3

4

5

6

6

Lysis Buffer

Lysate Vol.

7-8

Wash Buffer

2.5 BV

2.5 BV

9-10

Elution Buffer

0.5 BV

0.5 BV 0.5 BV 0.5 BV 0.5 BV 0.5 BV

Equipment List
Equipment Name

Amount

Resin Column

1

15 mL Falcon Tubes

2

2 mL Eppendorf Tubes

15

*Eppendorfs and falcon tubes should be autoclaved.
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Cleaning and Recharging Strep Resin
There is no protocol for cleaning Strep-Tactin resin.

Regenerating Strep Resin
The regeneration and re-use of Strep-Tactin Resin depends on the nature of its use. The manufacturer
recommends this regeneration procedure every 5 times of use.
Procedure
1. Wash the column with 6 BVs of Strep Regeneration Buffer.
2. Wash the column with 8 BVs of Strep Wash Buffer.
3. Store in Strep Wash Buffer at 4oC.

Desalting and Buffer Exchange

Procedure
1. Remove the top cap and pour off the buffer.
2. Add 20 mL of desired buffer and snap off the
bottom tip.
3. Drain buffer into waste container. (The column
will not run dry)
4. Add 3 mL of sample to the column. (If sample
is less than 3 mL, add buffer to reach total
volume of 3 mL)
5. Drain column into waste container.
6. Add 8 mL of buffer and collect 1 mL fractions.
(The first fractions will contain higher
molecular weights)
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A. Thaliana Plant Growth
1 Liter Solution
Murasighe and Skoog Media, (pH 5.7)
Media Preparation
Component
1. Mix and pH two liters of Murasighe and Skoog
Media (MS Media).
2. Aliquot 500 mL of MS Media into four, 1L flasks.
3. Cover flasks with aluminum foil and autoclave.

Amount

Murasighe and Skoog Basal
Medium

2.15

g

23 mM MES Sodium Salt

0.50

g

58.5 mM Sucrose

20.00

g

Whatman Paper Sterilization
1. Place a sheet of Whatman Paper into a petri dish.
2. Wet the Whatman Paper with 95% Ethanol to sterilize.
3. Repeat steps 1-2 three times for a total of four Whatman Papers.

Seed Sterilization (Protocol to start growth same day)
1. Suspend and soak 1 scoop (~30 uL) of A. thaliana seeds in an eppendorf of 1 mL of Seed
Sterilization Solution for 20 minutes.
2. Repeat step 1 three times for a total of four eppendorfs with seeds.
3. Decant Seed Sterilization Solution into a waste container.
4. Rinse seeds 5-7 times with 1 mL additions of sterile ddH2O, decanting into waste each time (if
necessary, centrifuge the seeds for better decanting).
5. Suspend the seeds in 1 mL of sterile ddH2O and quickly dump the contents into a cooled MS
Media flask (1 eppendorf per flask).
6. Tightly cover the flasks with aluminum foil and shake at 90 rpm under fluorescent growth lights
for 10 days.

Seed Sterilization (Protocol to prepare seeds for starting the growth another day)
1. Suspend and soak 1 scoop (~30 uL) of A. thaliana seeds in an eppendorf of 1 mL of Seed
Sterilization Solution for 20 minutes.
2. Repeat step 1 three times for a total of four eppendorfs with seeds.
3. Decant Seed Sterilization Solution into a waste container.
4. Rinse seeds 5-7 times with 1 mL additions of sterile ddH2O, decanting into waste each time.
5. Wash the seeds with 1 mL of Seed Washing Solution.
6. Decant Seed Washing Solution and rinse and decant twice with 95% Ethanol.
7. With a cut tip, pipette the seeds onto sterile Whatman Paper to dry. (1 eppendorf per paper)
8. On the desired day to begin the growth, sanitize your gloves by rubbing your hands together with
95% ethanol.
9. Flame-sterilize a spatula or forceps.
10. Once cooled, use the spatula or forceps to scrape the seeds into a cooled MS Media flask (1
eppendorf per flask).
11. Tightly cover the flasks with aluminum foil and shake at 90 rpm under fluorescent plant growth
lights for 10 days.
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200 mL Solution

200 mL Solution

Seed Sterilization Solution, (pH NA)
Component

Amount

Seed Washing Solution, (pH NA)
Component

Amount

Household Bleach

100

mL

Ethanol

140.0

mL

ddH2O

100

mL

ddH2O

60.0

mL

0.1% v/v Triton X-100

1

drop

0.1% v/v Triton X-100

1

drop

Running Gel Electrophoresis
1. Mix 15 μL of sample with 5 μL of 4X
SDS in an eppendorf tube.
2. Load 5 μL of MW ladder and 20 μL
of the eppendorf contents as pictured
on the right. (Skipping wells is
preferable, but not necessary)
3. Run the gel at 90V until the protein
front is past the stacking/resolving
line, then run at 120V until the protein
front reaches the bottom of the gel.

Staining Gel
1. Transfer the gel to an empty pipette tip container.
2. Cover the gel with Staining Solution.
3. Microwave for 45 seconds.
4. Put the gel on the shaker for 10 minutes.
5. Pour the Staining Solution into a bottle for future use, and rinse the gel with DI water
into the appropriate waste container.
6. Cover the gel with Destaining Solution.
7. Add a knotted KIM wipe, and place on the shaker overnight.
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Appendix III – SDS-PAGE Gels
atVHP63srt Gels
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atVHP164 Gels

68

sVL191h Gels
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Appendix IV – Sample Properties and Locations
Plasmids, Proteins, and Cells
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